Friedemann Honecker

11PUBLICATIONS
23CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsSpeciation and extinctionCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 22, 2024
Anticancer Activity of the Marine Triterpene Glycoside Cucumarioside A2-2 in Human Prostate Cancer Cells.

Ekaterina S Menchinskaya, Sergey A Dyshlovoy, Simone Venz

|Apr 20, 2022
Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors.

Dennis M Timmerman, Thomas F Eleveld, Sruthi Sriram

|Dec 18, 2020
Marine Compounds and Cancer: Updates 2020.

Sergey A Dyshlovoy, Friedemann Honecker

|Jan 18, 2020
Marine Drugs Acting as Autophagy Modulators.

Sergey A Dyshlovoy, Friedemann Honecker

|Jan 01, 2020
Marine Compounds and Cancer: The First Two Decades of XXI Century.

Sergey A Dyshlovoy, Friedemann Honecker

|Oct 01, 2019
Proteomic Comparison of Malignant Human Germ Cell Tumor Cell Lines.

Felix Bremmer, Hanibal Bohnenberger, Stefan Küffer

Pageof 2

Frequent Collaborators

7 joint publications

Sergey Dyshlovoy

2 joint publications

Christoph Oing

1 joint publications

Wael Y Mansour

1 joint publications

Felix Bremmer